International Flavors & Fragrances Inc. (IFF) is a publicly traded company in the Basic Materials — Chemicals - Specialty industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1.
Is International Flavors & Fragrances Inc. stock overvalued or undervalued in 2026?
International Flavors & Fragrances Inc. (IFF) trades at 86.1× earnings (P/E), above the median of the 156 materials companies over $2bn in Kaplio's universe. At the decade median (35.6×) $38 (-59 %); at its sector median (18.8×) $20 (-78 %).
Kaplio overview: International Flavors & Fragrances Inc.
Market cap $24B · 52 weeks $61 – $94 (4 % below the high) · P/E 86.1× · 2027 expected P/E 23.7× · Dividend 1.7 % · Next earnings November 3, 2026 · expected EPS $0.81 · Closing price, Oct 30 · accounts published Aug 4.
- Valuation: P/E 86.1× (expensive).
- Business: ROIC 3 % (weak).
- Balance sheet: Net debt/EBITDA 7.8× (fragile).
- Earnings: 5 of 8 (uneven).
What would it be worth at its usual multiples?
At the decade median (35.6×) $38 (-59 %); at its sector median (18.8×) $20 (-78 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in materials: 3 of 8 pass
- FCF yield 1.0 %, fails.
- Net debt / EBITDA (trough) 7.8×, fails.
- Dividend coverage 0.6×, fails.
- Capex / D&A 0.6×, fails.
- Altman Z-Score 1.3, fails.
- Gross margin 36.2 %, passes.
- P/B across cycles 1.7×, passes.
- Cycle-adjusted EV/EBITDA 19.4×, passes.
Against its peers (reference peers) — International Flavors & Fragrances Inc.: P/E 86.1×; EV/EBITDA 19.4×; ROIC 2.8 %; $23.7B. Balchem Corp (P/E 33.5×; EV/EBITDA 20.0×; ROIC 11.9 %; $5.4B), Sensient Technologies Corporation (P/E 31.7×; EV/EBITDA 21.0×; ROIC 8.6 %; $5.0B), Ashland Inc. (P/E 66.1×; EV/EBITDA 11.7×; ROIC 1.9 %; $3.4B).
Expensive or cheap against its last ten years?
P/E at each close: today 86.1× · median 35.6× · minimum 22.3× · maximum 87.4× · cheap below 31.1× · expensive above 67.0×. It has been cheaper than today 99% of the time over its last ten years.
Dividend
tight · Yield 1.7 % ($1.60 per share in 2025) · 5-year growth -11 % a year · Free cash flow coverage 1.0× · With $1,000 invested today you'd collect $17.20 a year ($1.43 a month).
Kaplio's reading: International Flavors & Fragrances Inc.
Updated on October 20, 2026 · accounts published on August 4, 2026
A low-return business with shrinking sales and a heavily indebted balance sheet
International Flavors & Fragrances trades at a P/E of 86.1× over the last 12 months, 142 % above its ten-year median of 35.6×.
- Is International Flavors & Fragrances expensive or cheap? Its P/E of 86.1× is 142 % above its ten-year median and higher than in 99 % of the past decade.
- How is the business doing? Revenue fell 5.2 % over the last 12 months and the 7.8 % operating margin trails its 2014-2025 average of 8.5 %.
- How strong is the balance sheet? Net debt was $24.57 per share in fiscal 2025, 7.8× EBITDA, and free cash flow covered the dividend only 0.6×.
- Can the balance sheet withstand the bottom of the cycle? International Flavors & Fragrances fails 5 of 8 sector checks, with net debt at 7.8× EBITDA against a healthy level below 3.0×.
- What to expect from the next earnings? Analysts expect EPS of $0.83 on November 3, 2026, after the 2026 EPS consensus fell 3.7 % in the last 30 days.
Is International Flavors & Fragrances expensive or cheap?
Over the last 12 months International Flavors & Fragrances trades at a P/E of 86.1×. Its ten-year median is 35.6× and its decade range runs from 22.3× to 87.4×, so the multiple sits near the top of its own history. The gap to the sector is wider still: the median P/E is 18.8×, which puts the stock 358 % above its peers. Collapsing earnings inflate that multiple, and other measures look calmer. EV/EBITDA of 19.4× is below its five-year average of 22.5×, and P/B is 1.7×. The stock is up 46 % in 12 months and trades within 1 % of its 52-week high of $94.15.
How is the business doing?
Sales shrank 5.2 % over the last 12 months and EPS fell 253.7 % year on year, which explains the stretched P/E. The operating margin of 7.8 % is close to the 7.7 % of fiscal 2025 but below the 8.5 % average for fiscal 2014-2025, so profitability has not recovered. Returns on capital are the weak spot. ROIC is 2.8 % over the last 12 months, 6.6 points below the sector median of 9.4 %. It topped 10 % in only one of the last ten fiscal years and bottomed at −7.5 % in 2023. An ROE of 2.1 % and a 2.9 % net margin point the same way.
How strong is the balance sheet?
On book values, leverage looks moderate: debt to equity was 0.45 and the current ratio 2.06 over the last 12 months. Measured against earnings, the picture changes. In fiscal 2025 net debt came to $24.57 per share, equal to 26 % of the current share price and 7.8× EBITDA. The Altman Z of 1.3 over the last 12 months sits in the danger zone, below the 1.81 threshold, and a Piotroski score of 6 out of 9 is middling. The 1.7 % dividend yield rests on thin cash, since free cash flow covered the payout only 0.6× in fiscal 2025.
Can the balance sheet withstand the bottom of the cycle?
In basic materials, results are tied to raw materials, so P/E alone misleads. Cost position and the durability of the dividend matter more. On that yardstick, the fiscal 2025 gross margin of 36.2 % clears the 30 % bar, but cash generation does not. Free cash flow yield is 1.0 % over the last 12 months against a healthy 8 %. Dividend cover is 0.6× against 1.3×, and in fiscal 2025 capex ran at 0.6× depreciation, below the 0.8× to 1.5× range. With net debt at 7.8× EBITDA and an Altman Z of 1.3, the balance sheet has little room for a downturn.
What to expect from the next earnings?
The last report, on August 4, 2026, delivered EPS of $0.82 against $1.07 expected. That 23.4 % miss was the largest surprise in absolute terms of the last eight quarters, although the company beat EPS estimates in 5 of those 8 quarters. Since then expectations have slipped. Over the last 30 days the 2026 EPS consensus dropped 3.7 %, from $3.44 to $3.32, and the 2026 revenue estimate fell 2.2 %. Analysts remain positive: 25 of 34 recommend buying, 8 holding and 1 selling. The $0.83 expected for the next quarter is barely above the last result.
How this was prepared: the data comes from companies' official filings, collected by a professional provider, and from Kaplio's analysis engine (trailing-12-month ratios, 10 years of history and sector medians computed across US-listed companies). The text is written from that data alone, every figure is checked against it before publication, and it is reviewed when the company reports results. This is not investment advice.
Investor methods verdict
Would Buffett approve International Flavors & Fragrances today?
The Buffett Method would not approve International Flavors & Fragrances today: it fails its quality rules. Business quality: 36 out of 100 (price not included). Kaplio assessment with data from the week of 2026-10-26; not investment advice.
Would Peter Lynch approve International Flavors & Fragrances today?
The Lynch Method would not approve International Flavors & Fragrances today: it fails its quality rules. Business quality: 100 out of 100 (price not included). Lynch classifies it as a turnaround. Kaplio assessment with data from the week of 2026-10-26; not investment advice.
Profitability
| Return on Equity | 2.05% |
| Return on Invested Capital | 2.79% |
| Return on Assets | 1.15% |
| Gross Margin | 37.52% |
| Operating Margin | 7.78% |
| Net Margin | 2.91% |
Financial Health
| Debt / Equity | 0.45 |
| Current Ratio | 2.06 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 1.34 |
Price Performance
| 1 month | +9.25% |
| 3 months | +14.63% |
| Year-to-date | +34.75% |
| 1 year | +44.21% |
| 3 years | +33.43% |
| 5 years | -36.97% |
| 10 years | -30.49% |
Dividend History
Paid in the last 12 months: $1.6000 per share in 4 payments.
| Date | Amount |
|---|---|
| 2026-09-18 | $0.4000 |
| 2026-06-18 | $0.4000 |
| 2026-03-20 | $0.4000 |
| 2025-12-19 | $0.4000 |
| 2025-09-29 | $0.4000 |
| 2025-06-20 | $0.4000 |
| 2025-03-21 | $0.4000 |
| 2024-12-20 | $0.4000 |
| 2024-09-20 | $0.4000 |
| 2024-06-21 | $0.4000 |
Amounts adjusted for stock splits.
Related companies: BCPC · MKC · INGR · SXT · ASH
Explore sector: Basic Materials · Chemicals - Specialty
More sections of IFF: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks